BASIL Trial Publications
The BASIL Trial outputs have been published in the form of peer reviewed manuscripts in scientific journals.
In addition, an executive summary and a full trial report can be found on the HTA website
2002
European Journal of Vascular & Endovascular Surgery. 24(5):411-6, 2002 Nov
Bypass or angioplasty for severe limb ischaemia? A Delphi Consensus Study.
2004
Journal of Vascular Surgery. 39(5):1026-32, 2004 May
Bypass versus angioplasty to treat severe limb ischemia: factors that affect treatment preferences of UK surgeons and interventional radiologists
2005
The Lancet 2005 Dec 3;366(9501):1925-34
2009
Seminars in Vascular Surgery. Lower Extremity Vein Bypass: Current Status 22:267-274 (2009)
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) Trial: What Are Its Implications?
Andrew W. Bradbury, BSc, MD, MBA, FRCSEd
2010
Journal of Vascular Surgery Volume 51, Issue 5, Supplement (May 2010)
Final Results of the BASIL Trial (Bypass Versus Angioplasty in Severe Ischaemia of the Leg) Edited by Andrew W. Bradbury
Bypass versus
Angioplasty in Severe Ischaemia of the Leg (BASIL) trial in perspective
Andrew W. Bradbury, BASIL trial Investigators and Participants
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An
intention-to-treat analysis of amputation-free and overall survival in patients
randomized to a bypass surgery-first or a balloon angioplasty-first
revascularization strategy
Andrew W. Bradbury, Donald J. Adam, Jocelyn Bell, John F. Forbes, F. Gerry R.
Fowkes, Ian Gillespie, Charles Vaughan Ruckley, Gillian M. Raab, BASIL trial
Participants
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis
of amputation free and overall survival by treatment received
Andrew W. Bradbury, Donald J. Adam, Jocelyn Bell, John F. Forbes, F. Gerry R.
Fowkes, Ian Gillespie, Charles Vaughan Ruckley, Gillian M. Raab, BASIL trial
Participants
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A
description of the severity and extent of disease using the Bollinger angiogram
scoring method and the TransAtlantic Inter-Society Consensus II classification
Andrew W. Bradbury, Donald J. Adam, Jocelyn Bell, John F. Forbes, F. Gerry R.
Fowkes, Ian Gillespie, Charles Vaughan Ruckley, Gillian M. Raab, BASIL trial
Participants
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial:
Health-related quality of life outcomes, resource utilization, and
cost-effectiveness analysis
John F. Forbes, Donald J. Adam, Jocelyn Bell, F. Gerry R. Fowkes, Ian Gillespie,
Gillian M. Raab, Charles Vaughan Ruckley, Andrew W. Bradbury, BASIL trial
Participants
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A
survival prediction model to facilitate clinical decision making
Andrew W. Bradbury, Donald J. Adam, Jocelyn Bell, John F. Forbes, F. Gerry R.
Fowkes, Ian Gillespie, Charles Vaughan Ruckley, Gillian M. Raab, BASIL trial
Participants
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped
for) dawn of evidence-based treatment for advanced limb ischemia
Michael S. Conte